Synlett 2012; 23(18): 2603-2608
DOI: 10.1055/s-0032-1317329
letter
© Georg Thieme Verlag Stuttgart · New York

Transition-Metal-Catalyzed Arylation of 1-Deazapurines via C–H Bond Activation

Viktor O. Iaroshenko*
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   Email: viktor.iaroshenko@uni-rostock.de   Email: iva108@googlemail.com
b   National Taras Shevchenko University, 62 Volodymyrska st., Kyiv-33, 01033, Ukraine
,
Iftikhar Ali
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   Email: viktor.iaroshenko@uni-rostock.de   Email: iva108@googlemail.com
,
Satenik Mkrtchyan
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   Email: viktor.iaroshenko@uni-rostock.de   Email: iva108@googlemail.com
,
Volodymyr Semeniuchenko
b   National Taras Shevchenko University, 62 Volodymyrska st., Kyiv-33, 01033, Ukraine
,
Dmytro Ostrovskyi
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   Email: viktor.iaroshenko@uni-rostock.de   Email: iva108@googlemail.com
,
Peter Langer
a   Institut für Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany   Fax: +49(381)49864112   Email: viktor.iaroshenko@uni-rostock.de   Email: iva108@googlemail.com
c   Leibniz-Institut für Katalyse e. V. an der Universität Rostock, Albert-Einstein-Str. 29a, 18059 Rostock, Germany
› Author Affiliations
Further Information

Publication History

Received: 02 August 2012

Accepted after revision: 06 September 2012

Publication Date:
01 October 2012 (online)


Abstract

Transition-metal-catalyzed arylation of imidazo[4,5-b]pyridines (known as 1-deazapurines) is reported. 1-Deazapurines were synthesized from 5-aminoimidazoles, generated in situ by the reaction of methyl N-(cyanomethyl)formimidate with primary amines.

Supporting Information

 
  • References

  • 2 Joseph EC, Rees JA, Dayan AD. Toxicol. Pathology 1996; 24: 436
  • 3 Ida K, Otsubo N, Kuboyama T, Arai H, Watanabe A, Saki M, Hiura N, Manabe H, Tekada H, Saito J. WO2005082905, 2005 ; Chem. Abstr. 2005, 143, 266925
    • 4a Bavetsias V, Sun C, Bouloc N, Reynisson J, Workman P, Linardopoulos S, McDonald E. Bioorg. Med. Chem. Lett. 2007; 17: 6567
    • 4b Chan F, Sun C, Perumal M, Nguyen Q.-D, Bavetsias V, McDonald E, Martins V, Wilsher NE, Raynaud MValenti S, Eccles R, te Poele P, Workman FI, Aboagye EO, Linardopoulos S. Mol. Cancer Ther. 2007; 6: 3147
    • 6a Cristalli G, Vittori S, Eleuteri A, Grifantini M, Volpini R, Lupidi G, Capolongo L, Pesenti E. J. Med. Chem. 1991; 34: 2226
    • 6b Bergman AM, Cristalli G, Vittori S, Wang J, Eriksson S, Peters G. Nucleosides Nucleotides 1999; 18: 897
  • 7 Bennett LJr, Smithers D, Rose LM, Adamson DJ, Brockman RW. Biochem. Pharmacol. 1984; 33: 261
  • 8 Clark RL, Pessolano AA, Shen T.-Y, Jacobus DP, Jones H, Lotti VJ, Flataker LM. J. Med. Chem. 1978; 21: 965
  • 11 Burnstock G. Nat. Rev. Drug Discovery 2008; 7: 575
  • 12 Chu CK. Recent Advances in Nucleosides: Chemistry and Chemotherapy. Elsevier; Amsterdam: 2002
    • 16a Iaroshenko VO, Mkrtchyan S, Gevorgyan A, Vilches-Herrera M, Sevenard DV, Villinger AT, Ghochikyan V, Saghiyan A, Sosnovskikh VY, Langer P. Tetrahedron 2012; 68: 2532
    • 16b Iaroshenko VO, Mkrtchyan S, Ghazaryan G, Hakobyan A, Maalik A, Supe L, Villinger A, Tolmachev A, Ostrovskyi D, Sosnovskikh VY, Ghochikyan TV, Langer P. Synthesis 2011; 469
    • 16c Iaroshenko VO, Ostrovskyi D, Petrosyan A, Mkrtchyan S, Villinger A, Langer P. J. Org. Chem. 2011; 76: 2899
    • 16d Iaroshenko VO, Sevenard DV, Kotljarov A, Volochnyuk DM, Tolmachev AO, Sosnovskikh VY. Synthesis 2009; 731
    • 16e Iaroshenko VO, Specowius V, Vlach K, Vilches-Herrera M, Ostrovskyi D, Mkrtchyan S, Villinger A, Langer P. Tetrahedron 2011; 67: 5663
    • 16f Ostrovskyi D, Iaroshenko VO, Petrosyan A, Dudkin S, Ali I, Villinger A, Tolmachev A, Langer P. Synlett 2010; 2299
  • 19 Ozden S, Ozden T, Gumus F, Akin S. Ankara Universitesi Eczacilik Fakultesi Dergisi 1985; 15: 79 ; Chem. Abstr. 1988, 108, 112330
  • 20 Seregin IV, Gevorgyan V. Chem. Soc. Rev. 2007; 36: 1173
  • 26 Iaroshenko VO, Ostrovskyi D, Milyutina M, Maalik A, Villinger A, Tolmachev A, Volochnyuk DM, Langer P. Adv. Synth. Catal. 2012; 2495
  • 27 General Procedure for the Synthesis of Compounds 6a-n Using Cu and Pd Catalyst: DMF (8 mL) was added to an argon-purged pressure tube containing 3H-imidazo[4,5-b]pyridine 5ah (1 mmol), Pd(OAc)2 (0.05 mmol, 5 mol%), CuI (3 mmol), ArX (2 mmol), and Cs2CO3 (2.5 mmol). The reaction mixture was stirred at 150 °C for 30–60 h. After cooling to r.t., the solvent was evaporated under reduced pressure and the products were isolated and purified by column chromatography (gradient elution n-heptane–EtOAc, EtOAc–i-PrOH)
  • 28 3-Phenethyl-2-phenyl-5-(thiophen-2-yl)-7-(trifluoromethyl)-3H-imidazo[4,5-b]pyridine (6i): Bright-yellow solid; mp 137–139 °C; 1H NMR (300.13 MHz, CDCl3): δ = 3.14 (t, J = 6.99, 2 H, CH2), 4.57 (t, J = 7.55, 2 H, CH2), 6.99 (d, J = 8.12 Hz, 2 H, ArH), 7.12–7.16 (m, 2 H, ArH), 7.28–7.44 (m, 5 H, ArH), 7.51–7.59 (m, 2 H, ArH), 7.63 (d, J = 7.18 Hz, 2 H, ArH), 7.76 (s, 1 H, ArH); 13C NMR (62.89 MHz, CDCl3): δ = 35.6 (CH2), 45.6 (CH2), 110.3 (q, 3 J C–F = 4.12 Hz, CH), 122.8 (q, 1 J C–F = 274.00 Hz, CF3), 124.2 (CH), 125.8 (2CH), 126.0 (CH), 126.9 (CH), 127.9 (CH), 128.3 (q, 2 J C–F = 33.88 Hz, C), 128.7 (CH), 128.8 (3CH), 129.0 (CH), 129.3 (CH), 129.5 (C), 130.4 (CH), 134.2 (C), 137.4 (C), 143.4 (C), 146.6 (C), 149.8 (C), 156.5 (C); 19F NMR (282.40 MHz, CDCl3): δ = –61.99 (ArCF3); IR (ATR): 3025 (w), 2960 (s), 2927 (m), 2868 (w), 1907 (w), 1732 (w), 1600 (m), 1544 (m), 1496 (m), 1467 (w), 1453 (w), 1443 (w), 1418 (w), 1384 (s), 1367 (w), 1339 (w), 1329 (w), 1309 (w), 1271 (m), 1250 (m), 1228 (w), 1155 (w), 1125 (s), 1099 (w), 1073 (w), 1049 (w), 1029 (w), 1020 (w), 1004 (w), 959 (w), 942 (w), 929 (w), 898 (w), 868 (m), 846 (w), 833 (w), 809 (s), 779 (w), 755 (m), 739 (w), 696 (w), 684 (m), 666 (w), 618 (w), 609 (w), 586 (w), 558 (m), 532 (w) cm–1; GC-MS (EI, 70 eV): m/z (%) = 449 (26) [M]+, 358 (2), 345 (100), 324 (1), 242 (1), 208 (2), 186 (1), 146 (1), 105 (1), 91 (1), 77 (2); HRMS (ESI): m/z [M + H]+ calcd for C25H19F3N3S: 450.12463; found: 450.12452
  • 30 General Procedure for the Synthesis of Compounds 6a–n Using Ni Catalyst: DMF (8 mL) was added to an argon-purged pressure tube containing 3H-imidazo[4,5-b]pyridine 5ah (1 mmol), [NiCl2(PPh3)2] (0.05 mmol, 5 mol%), ArX (2 mmol), and K2CO3 (2.5 mmol). The reaction mixture was stirred at 110 °C for 15 h. After cooling to r.t., the solvent was evaporated under reduced pressure and the products were isolated and purified by column chromatography (gradient elution n-heptane–EtOAc, EtOAc–i-PrOH)
  • 31 Hegedus LS In Organometallics in Synthesis . Schlosser M. John Wiley and Sons; Chichester: 2002: 1123-1217
  • 32 Pintori DG, Greaney MF. J. Am. Chem. Soc. 2011; 133: 1209
  • 33 Huang J, Chan J, Chen Y, Borths CJ, Baucom KD, Larsen RD, Faul MM. J. Am. Chem. Soc. 2010; 132: 3674
    • 34a Schareina T, Zapf A, Mägerlein W, Müller N, Beller M. Synlett 2007; 555
    • 34b Schareina T, Zapf A, Mägerlein W, Müller N, Beller M. Chem.–Eur. J. 2007; 13: 6249